*Canceled through April 17. This single-day, small-group, hands-on ultrasound (US) course is designed to teach the basic principles of pediatric contrast-enhanced US including intravenous and intracavitary applications.
Three years after FDA approval of the first CAR-T therapy, Dr. Grupp will review outcomes data and provide an update on advancements and new trials in the field of cancer immunotherapy for patients with relapsed acute lymphoblastic leukemia (ALL).
During this webinar, we will present the general approach to patients with a possible cancer predisposition syndrome, review a few of the more common cancer surveillance syndromes, and discuss future directions in the field of pediatric cancer predisposition.
Optic pathway gliomas (OPGs) are low-grade astrocytomas that occur in 15-20% of children with neurofibromatosis type 1 (NF1). Although rarely life-threatening, these tumors can cause significant vision loss. Given this, the main goal of management is to reduce the risk of permanent visual loss.
Join us as we highlight breaking research in pediatric cardiology and explore the latest developments in our ever-expanding field.